Brazilian scientists are using an approach for developing a Covid-19 vaccine that runs counter to the methods employed thus far by the pharmaceutical industry and groups of researchers in other countries.
Their project is being carried out at the immunology laboratory of the University of Sao Paulo Medical School's Heart Institute, where specialists in different research areas have been working over the past month on a vaccine based on artificial particles that resemble severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Dr. Jorge Kalil, the laboratory's director and project coordinator, told Efe.